ArticleJournal of diabetes and treatment2024
Sex-Specific Elevated Fasting Glucose in Patients with Major Depressive Disorder.
Article in Journal of diabetes and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: This study aimed to test whether the relationship between Major Depressive Disorder (MDD) and prediabetes is sex-specific and explored potential pathways. Methods: One hundred sixty-eight participants were enrolled, and 142 completed the study for data analysis. Participants were divided into patients with MDD (n=58) and without MDD, i.e., controls (n=84). The Oral Glucose Tolerance Test (OGTT) was conducted, and the serum cortisol levels of each participant were also measured. Demographic variables were analyzed using t-tests or chi-square tests. Covariance analysis was conducted to test the measures derived from OGTT and cortisol levels between groups. Results: There was no difference in fasting glucose, 2-hour post-prandial levels, and indices of insulin sensitivity between MDD and control groups. However, in a stratified and sex-comparative analysis, female participants with MDD had higher fasting glucose and cortisol levels than female controls, but this was not seen in males. Also, fasting glucose was positively correlated with the severity of depression in females with MDD. Conclusion: Females with MDD have the highest risk of developing prediabetes compared to female controls and males, possibly through cortisol. Fasting glucose and cortisol could be biomarkers to recognize prediabetes in females with MDD for early intervention and better outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.